These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Veterinary DNA vaccines. van Drunen Littel-van den Hurk S; Braun RP; Babiuk LA Methods Mol Med; 2000; 29():79-94. PubMed ID: 21374311 [TBL] [Abstract][Full Text] [Related]
45. Production of recombinant subunit vaccines: protein immunogens, live delivery systems and nucleic acid vaccines. Liljeqvist S; Ståhl S J Biotechnol; 1999 Jul; 73(1):1-33. PubMed ID: 10483112 [TBL] [Abstract][Full Text] [Related]
47. [New vaccines. What can we expect in the coming years?]. Bjune G; Nøkleby HM Tidsskr Nor Laegeforen; 1995 Oct; 115(24):3032-4. PubMed ID: 7570534 [TBL] [Abstract][Full Text] [Related]
48. The Jennerian heritage: new generation vaccines for all the world's children and adults. Nossal GJ; Lambert PH Biologicals; 1997 Jun; 25(2):131-5. PubMed ID: 9236039 [No Abstract] [Full Text] [Related]
49. [Perspective of development of vaccine against infectious diseases]. Yamanishi K Nihon Rinsho; 2011 Sep; 69(9):1535-40. PubMed ID: 21922749 [TBL] [Abstract][Full Text] [Related]
50. A short review of biotechnological methods of relevance to modern vaccine development. Helland DE; Hey AW Scand J Infect Dis Suppl; 1990; 76():32-8. PubMed ID: 2102019 [TBL] [Abstract][Full Text] [Related]
51. [Classic vaccinology and advances in vaccine design]. Criado MT; Sánchez S; Ferreirós CM Enferm Infecc Microbiol Clin; 2008 Nov; 26(9):564-72. PubMed ID: 19100177 [TBL] [Abstract][Full Text] [Related]
52. Viral vaccines and their manufacturing cell substrates: New trends and designs in modern vaccinology. Rodrigues AF; Soares HR; Guerreiro MR; Alves PM; Coroadinha AS Biotechnol J; 2015 Sep; 10(9):1329-44. PubMed ID: 26212697 [TBL] [Abstract][Full Text] [Related]
53. [New vaccines in the age of genetic engineering]. Nolte F Immun Infekt; 1993 Oct; 21(5):142-6. PubMed ID: 8253480 [TBL] [Abstract][Full Text] [Related]
54. Novel vaccine design based on genomics data analysis: A review. Lu G; Shan S; Zainab B; Ayaz Z; He J; Xie Z; Rashid U; Zhang D; Mehmood Abbasi A Scand J Immunol; 2021 Mar; 93(3):e12986. PubMed ID: 33043473 [TBL] [Abstract][Full Text] [Related]
55. Successes and failures: Worldwide vaccine development and application. Francis DP Biologicals; 2010 Sep; 38(5):523-8. PubMed ID: 20685134 [TBL] [Abstract][Full Text] [Related]
56. New technology for improved vaccine safety and efficacy. Roth JA; Henderson LM Vet Clin North Am Food Anim Pract; 2001 Nov; 17(3):585-97, vii. PubMed ID: 11692510 [TBL] [Abstract][Full Text] [Related]
58. Reverse vaccinology in the 21st century: improvements over the original design. Donati C; Rappuoli R Ann N Y Acad Sci; 2013 May; 1285():115-32. PubMed ID: 23527566 [TBL] [Abstract][Full Text] [Related]